This page has moved. Click here to view.

Prostate Cancer

The average age at diagnosis of prostate cancer is 73 years. The age-adjusted death rate from prostate cancer has not prostate cancer, cancer of the prostate, PSA, prostate specific antigen changed appreciably in

Clinical Evaluation

The prevalence of prostate cancer is 30% in men over the age of 50. One in six men will be diagnosed with prostate cancer during their

Some patients with prostate cancer may have obstructive urinary symptoms similar to benign prostatic hypertrophy; some patients may have weight loss and bone pain. Most patients have no symptoms, only an elevated prostate specific antigen found on routine screening.

Physical Exam: Digital rectal exam is used to assess the nodule for extension beyond prostate edge, firmness, prostate cancer, cancer of the prostate, PSA, prostate specific antigen fixation, or induration.

Prostate Specific Antigen (PSA) prostatic cancer

PSA is a glycoprotein produced by both benign and malignant prostatic epithelium.

Each gram of prostate tissue increases serum PSA by about 0.3 ng/mL, but each gram of prostate cancer increases prostate cancer, cancer of the prostate, cancer, PSA, prostate specific antigen serum PSA by Prostate Cancer about 3.5 ng/mL.

PSA screening improves prostate cancer, cancer of the prostate, cancer, PSA, prostate specific antigen detection of Prostate Cancer prostate cancer at an earlier stage. However, an improvement prostate cancer, cancer of the prostate, cancer, PSA, prostate specific antigen in survival has not prostate cancer, cancer of the prostate, PSA, prostate specific antigen